BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10679039)

  • 1. Peripheral neuroblastic tumors: pathologic classification based on recommendations of international neuroblastoma pathology committee (Modification of shimada classification).
    Joshi VV
    Pediatr Dev Pathol; 2000; 3(2):184-99. PubMed ID: 10679039
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.
    Joshi VV; Cantor AB; Altshuler G; Larkin EW; Neill JS; Shuster JJ; Holbrook CT; Hayes FA; Castleberry RP
    Cancer; 1992 Apr; 69(8):2183-96. PubMed ID: 1544124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of peripheral neuroblastic tumors].
    Wang L; He LJ; Shimada H
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroblastoma classification.
    de Sa D
    Pediatr Dev Pathol; 2000; 3(5):506-7. PubMed ID: 10890940
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathology of neuroblastic tumors.
    Joshi VV; Silverman JF
    Semin Diagn Pathol; 1994 May; 11(2):107-17. PubMed ID: 7809504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
    Sano H; Bonadio J; Gerbing RB; London WB; Matthay KK; Lukens JN; Shimada H
    Eur J Cancer; 2006 May; 42(8):1113-9. PubMed ID: 16624549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
    Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
    Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumors of the neuroblastoma group.
    Shimada H
    Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
    Munchar MJ; Sharifah NA; Jamal R; Looi LM
    Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympathicus tumors in childhood in the ORL sphere].
    Stĕpánková V
    Cesk Otolaryngol; 1979 Feb; 28(1):52-5. PubMed ID: 421292
    [No Abstract]   [Full Text] [Related]  

  • 19. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.
    Shimada H; Chatten J; Newton WA; Sachs N; Hamoudi AB; Chiba T; Marsden HB; Misugi K
    J Natl Cancer Inst; 1984 Aug; 73(2):405-16. PubMed ID: 6589432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.